Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: Nationwide Korean study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, S.J. | - |
dc.contributor.author | Suh, C.W. | - |
dc.contributor.author | Lee, S.I. | - |
dc.contributor.author | Kim, W.S. | - |
dc.contributor.author | Lee, W.S. | - |
dc.contributor.author | Kim, H.J. | - |
dc.contributor.author | Choi, C.W. | - |
dc.contributor.author | Kim, J.S. | - |
dc.contributor.author | Shin, H.-J. | - |
dc.date.accessioned | 2021-09-05T16:01:22Z | - |
dc.date.available | 2021-09-05T16:01:22Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/100752 | - |
dc.description.abstract | Background/Aims: In Asia, the incidence of non-Hodgkin lymphoma (NHL) has increased in recent decades. Waldeyer's ring (WR) is the most common site of NHL involving the head and neck. In this study, the pathological distribution of WR-NHL and its clinical features were analyzed retrospectively. Methods: From January 2000 through December 2010, we analyzed the medical records of 328 patients from nine Korean institutions who were diagnosed with WR-NHL. Results: The study group comprised 197 male and 131 female patients with a median age of 58 years (range, 14 to 89). The rate of localized disease (stage I/II) was 64.9%, and that of low-risk disease (low/low-intermediate, as defined by the International Prognostic Index) was 76.8%. Diffuse large B-cell lymphoma (DLBCL; 240 patients, 73.2%) was the most common pathologic subtype, followed by peripheral T-cell lymphoma (14 patients, 4.3%) and nasal NK/T-cell lymphoma (14 patients, 4.3%). WR-NHL occurred most frequently in the tonsils (199 patients, 60.6%). Extranodal involvement was greater with the T-cell subtype (20 patients, 42.5%) compared with the B-cell subtype (69 patients, 24.5%). Multivariate analyses showed that age ≥ 62 years, T-cell subtype, and failure to achieve complete remission were significant risk factors for overall survival. Conclusions: DLBCL was found to have a higher incidence in Korea than those incidences reported by other WR-NHL studies. T-cell lymphoma occurred more frequently than did follicular lymphoma. T-cell subtype, age ≥ 62 years, and complete remission failure after first-line treatment were significant poor prognostic factors for overall survival according to the multivariate analysis. © 2014 The Korean Association of Internal Medicine. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Association of Internal Medicine | - |
dc.subject | adolescent | - |
dc.subject | aged | - |
dc.subject | article | - |
dc.subject | cancer incidence | - |
dc.subject | cancer localization | - |
dc.subject | cancer prognosis | - |
dc.subject | cancer regression | - |
dc.subject | cancer risk | - |
dc.subject | cancer staging | - |
dc.subject | cancer survival | - |
dc.subject | clinical feature | - |
dc.subject | female | - |
dc.subject | follicular lymphoma | - |
dc.subject | human | - |
dc.subject | Korean (people) | - |
dc.subject | large cell lymphoma | - |
dc.subject | low risk population | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | NK T cell lymphoma | - |
dc.subject | nonhodgkin lymphoma | - |
dc.subject | overall survival | - |
dc.subject | peripheral T cell lymphoma | - |
dc.subject | retrospective study | - |
dc.subject | risk factor | - |
dc.subject | treatment outcome | - |
dc.subject | Waldeyer ring | - |
dc.subject | adult | - |
dc.subject | age | - |
dc.subject | clinical trial | - |
dc.subject | disease free survival | - |
dc.subject | Head and Neck Neoplasms | - |
dc.subject | incidence | - |
dc.subject | Kaplan Meier method | - |
dc.subject | Lymphoma, Non-Hodgkin | - |
dc.subject | middle aged | - |
dc.subject | mortality | - |
dc.subject | multicenter study | - |
dc.subject | multivariate analysis | - |
dc.subject | pathology | - |
dc.subject | proportional hazards model | - |
dc.subject | recurrent disease | - |
dc.subject | remission | - |
dc.subject | South Korea | - |
dc.subject | time | - |
dc.subject | very elderly | - |
dc.subject | young adult | - |
dc.subject | Adolescent | - |
dc.subject | Adult | - |
dc.subject | Age Factors | - |
dc.subject | Aged | - |
dc.subject | Aged, 80 and over | - |
dc.subject | Disease-Free Survival | - |
dc.subject | Female | - |
dc.subject | Head and Neck Neoplasms | - |
dc.subject | Humans | - |
dc.subject | Incidence | - |
dc.subject | Kaplan-Meier Estimate | - |
dc.subject | Lymphoma, Extranodal NK-T-Cell | - |
dc.subject | Lymphoma, Large B-Cell, Diffuse | - |
dc.subject | Lymphoma, Non-Hodgkin | - |
dc.subject | Lymphoma, T-Cell, Peripheral | - |
dc.subject | Male | - |
dc.subject | Middle Aged | - |
dc.subject | Multivariate Analysis | - |
dc.subject | Neoplasm Staging | - |
dc.subject | Proportional Hazards Models | - |
dc.subject | Recurrence | - |
dc.subject | Remission Induction | - |
dc.subject | Republic of Korea | - |
dc.subject | Retrospective Studies | - |
dc.subject | Risk Factors | - |
dc.subject | Time Factors | - |
dc.subject | Treatment Outcome | - |
dc.subject | Young Adult | - |
dc.title | Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: Nationwide Korean study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, C.W. | - |
dc.identifier.doi | 10.3904/kjim.2014.29.3.352 | - |
dc.identifier.scopusid | 2-s2.0-84901302597 | - |
dc.identifier.bibliographicCitation | Korean Journal of Internal Medicine, v.29, no.3, pp.352 - 360 | - |
dc.relation.isPartOf | Korean Journal of Internal Medicine | - |
dc.citation.title | Korean Journal of Internal Medicine | - |
dc.citation.volume | 29 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 352 | - |
dc.citation.endPage | 360 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001874388 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | adolescent | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cancer incidence | - |
dc.subject.keywordPlus | cancer localization | - |
dc.subject.keywordPlus | cancer prognosis | - |
dc.subject.keywordPlus | cancer regression | - |
dc.subject.keywordPlus | cancer risk | - |
dc.subject.keywordPlus | cancer staging | - |
dc.subject.keywordPlus | cancer survival | - |
dc.subject.keywordPlus | clinical feature | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | follicular lymphoma | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | Korean (people) | - |
dc.subject.keywordPlus | large cell lymphoma | - |
dc.subject.keywordPlus | low risk population | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | NK T cell lymphoma | - |
dc.subject.keywordPlus | nonhodgkin lymphoma | - |
dc.subject.keywordPlus | overall survival | - |
dc.subject.keywordPlus | peripheral T cell lymphoma | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | risk factor | - |
dc.subject.keywordPlus | treatment outcome | - |
dc.subject.keywordPlus | Waldeyer ring | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | age | - |
dc.subject.keywordPlus | clinical trial | - |
dc.subject.keywordPlus | disease free survival | - |
dc.subject.keywordPlus | Head and Neck Neoplasms | - |
dc.subject.keywordPlus | incidence | - |
dc.subject.keywordPlus | Kaplan Meier method | - |
dc.subject.keywordPlus | Lymphoma, Non-Hodgkin | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | mortality | - |
dc.subject.keywordPlus | multicenter study | - |
dc.subject.keywordPlus | multivariate analysis | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | proportional hazards model | - |
dc.subject.keywordPlus | recurrent disease | - |
dc.subject.keywordPlus | remission | - |
dc.subject.keywordPlus | South Korea | - |
dc.subject.keywordPlus | time | - |
dc.subject.keywordPlus | very elderly | - |
dc.subject.keywordPlus | young adult | - |
dc.subject.keywordPlus | Adolescent | - |
dc.subject.keywordPlus | Adult | - |
dc.subject.keywordPlus | Age Factors | - |
dc.subject.keywordPlus | Aged | - |
dc.subject.keywordPlus | Aged, 80 and over | - |
dc.subject.keywordPlus | Disease-Free Survival | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Head and Neck Neoplasms | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Incidence | - |
dc.subject.keywordPlus | Kaplan-Meier Estimate | - |
dc.subject.keywordPlus | Lymphoma, Extranodal NK-T-Cell | - |
dc.subject.keywordPlus | Lymphoma, Large B-Cell, Diffuse | - |
dc.subject.keywordPlus | Lymphoma, Non-Hodgkin | - |
dc.subject.keywordPlus | Lymphoma, T-Cell, Peripheral | - |
dc.subject.keywordPlus | Male | - |
dc.subject.keywordPlus | Middle Aged | - |
dc.subject.keywordPlus | Multivariate Analysis | - |
dc.subject.keywordPlus | Neoplasm Staging | - |
dc.subject.keywordPlus | Proportional Hazards Models | - |
dc.subject.keywordPlus | Recurrence | - |
dc.subject.keywordPlus | Remission Induction | - |
dc.subject.keywordPlus | Republic of Korea | - |
dc.subject.keywordPlus | Retrospective Studies | - |
dc.subject.keywordPlus | Risk Factors | - |
dc.subject.keywordPlus | Time Factors | - |
dc.subject.keywordPlus | Treatment Outcome | - |
dc.subject.keywordPlus | Young Adult | - |
dc.subject.keywordAuthor | Diffuse large b-cell lymphoma | - |
dc.subject.keywordAuthor | Head and neck | - |
dc.subject.keywordAuthor | Non-hodgkin lymphoma | - |
dc.subject.keywordAuthor | T-cell lymphoma | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.